August 2, 2019 – Houston, Texas – Acessa Health Inc., developer of the Acessa ProVu System is proud to announce that Jonathan Faro, MD of Specialists in Obstetrics and Gynecology completed the Acessa procedure for uterine fibroids using the latest Acessa ProVu technology at Woman’s Hospital of Texas, joining over 100 physicians offering the procedure with over 3,000 women treated to date.
Also known as laparoscopic radiofrequency ablation (Lap-RFA), the Acessa Procedure is a minimally invasive procedure used to treat symptomatic uterine fibroids. It is a uterine-sparing alternative to hysterectomy. Comprehensive data on the procedure includes over 35 publications with 750 patients studied. The Acessa Procedure revolutionizes the current standard of care for fibroids, hysterectomy or myomectomy, by treating fibroids laparoscopically without cutting or suturing of the uterine tissue – including fibroids outside the uterine cavity and within the uterine walls. Patients typically go home the same day, experience minimal discomfort, and return to a normal state of activity within three to five days(2).
Uterine fibroids cause abnormally heavy menstruation, pelvic pain and bulk symptoms, and studies have shown that over 70% of women experience them(1). “The women of Texas deserve all the options when dealing with uterine fibroids, including options that spare the female anatomy,” said Dr. Faro. “The Acessa Procedure is the solution we have been waiting for. I’m able to treat nearly all sizes and locations of fibroids and relieve woman’s symptoms with minimal downtime and remarkable outcomes proven to be the same or better than other surgical fibroid alternatives.”
When asked about how the Acessa procedure changes his practice, Dr. Faro said, “Women present to me with such debilitating symptoms, like heavy bleeding, bulk, and pelvic pain, that they are unable to perform routine activities. Before Acessa, the options were often limited to major surgery (myomectomy or hysterectomy). Those surgeries can require a recovery period of six to eight weeks. Acessa changes the options for women.”
Dr. Faro explained that Woman’s Hospital of Texas is the ideal facility for performing Acessa, with a woman-first mentality to providing healthcare. The Acessa Procedure allows Woman’s Hospital of Texas to do just that, as together Acessa Health and Woman’s Hospital of Texas are improving upon the current standard of care offered to women in Texas. Offering Acessa as a viable, uterine-sparing option for patients aligns well with Woman’s Hospital of Texas’ reputation as a premier site for women to receive safe, compassionate and accessible healthcare.
“We could not be more thrilled to have Dr. Faro and Woman’s Hospital of Texas as partners in advancing options for women,” said Kim Rodriguez, President and Chief Executive Officer of Acessa Health Inc. “Given the hospital’s outstanding reputation in the woman’s health arena and Dr. Faro’s excellence in minimally invasive gynecology surgery, we are poised to do great things for women in Houston.”
About Jonathan Faro, MD – Dr. Jonathan Faro is board certified in Ob/Gyn and has practiced in Houston since graduating from residency in 2011. After completing a combined MD/PhD at Rush University Medical Center in Chicago, Dr. Jonathan Faro moved to Houston to start his residency at The University of Texas Health Science Center. Here, he served as an Administrative Chief Resident during his final year of training. After completing his residency training, he joined the faculty as an Assistant Professor at UT-Houston in the department of Ob/Gyn. Dr. Jonathan Faro’s research interests have focused on robotic surgery and the development of a novel test for use in identifying certain infectious diseases. He has had abstracts accepted to conferences hosted by the Society of Maternal Fetal Medicine, American Society of Microbiology, the Central Association of Ob/Gyn, and the Infectious Diseases Society of Ob/Gyn. In addition, he was awarded a grant from Intuitive Surgical in 2012 as the PI of a study examining surgeon fatigue following laparoscopy. Dr. Jonathan Faro is looking forward to continuing his research in Ob/Gyn, and providing the best care possible to his patients. Dr. Jonathan Faro currently maintains privileges at The Woman’s Hospital of Texas, and is excited to start the next step in his career there, in a unique Practice with his father, Sebastian, and cousin, Connie
About Acessa Health Inc. – Acessa Health is a woman’s health innovator dedicated to advancing minimally invasive, uterine-sparing solutions for women with symptomatic fibroids. The company introduced the use of laparoscopic radiofrequency ablation for the treatment of uterine fibroids and is committed to ensuring that women have more options by developing technologies that improve the lives of its patients. Acessa Health’s headquarters are in Austin, Texas. For more information, visit AcessaProcedure.com.
- Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–107. doi: 10.1067/mob.2003.99.
- Yelena Havryliuk, MD, Robert Setton, MD, John Carlow, EdD, MPH, Barry D. Shaktman, MD, Management of Symptomatic Fibroids: Review and Meta-Analysis of the Literature (2006 -2016), Journal of the Society of Laparoendoscopic Surgeons, Vol. 21 (3) Jul-Sept 201
Media Contact: Kim Rodriguez
Acessa Health Inc. 877.412.3828